Role of lipopolysaccharide in the induction of type I interferon-dependent cross-priming and IL-10 production in mice by meningococcal outer membrane vesicles (Q48004357)

From Wikidata

Jump to navigation Jump to search

scientific article published on 31 January 2009

Language	Label	Description	Also known as
English	Role of lipopolysaccharide in the induction of type I interferon-dependent cross-priming and IL-10 production in mice by meningococcal outer membrane vesicles	scientific article published on 31 January 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19368771

Role of lipopolysaccharide in the induction of type I interferon-dependent cross-priming and IL-10 production in mice by meningococcal outer membrane vesicles (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19368771

lipopolysaccharide

0 references

6

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19368771

author name string

Vanessa Durand

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19368771

Joanne Mackenzie

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19368771

Joel de Leon

3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19368771

Circe Mesa

4

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19368771

Valérie Quesniaux

5

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19368771

Agnes Le Bon

7

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19368771

Simon Y C Wong

8

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19368771

language of work or name

0 references

publication date

31 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19368771

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19368771

27

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19368771

13

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19368771

1912-1922

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19368771

Epidemiology and pathogenesis of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Immunologic response of man to group B meningococcal polysaccharide vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Meningococcal surrogates of protection--serum bactericidal antibody activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Outer membrane vesicle vaccines made from short-chain lipopolysaccharide mutants of serogroup B Neisseria meningitidis: effect of the carbohydrate chain length on the immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Comparison of functional immune responses in humans after intranasal and intramuscular immunisations with outer membrane vesicle vaccines against group B meningococcal disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Immunogenicity and safety testing of a group B intranasal meningococcal native outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Human immunity to the meningococcus. II. Development of natural immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Development of natural immunity to Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Characterization of humoral and cellular immune responses elicited by meningococcal carriage.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Neisseria lactamica protects against experimental meningococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Human immunity to the meningococcus. I. The role of humoral antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Evidence for Naturally Acquired T Cell-Mediated Mucosal Immunity to Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Regulation of Th-1 T cell-dominated immunity to Neisseria meningitidis within the human mucosa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Local and systemic antibody responses in mice immunized intranasally with native and detergent-extracted outer membrane vesicles from Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Safety and immunogenicity testing of an intranasal group B meningococcal native outer membrane vesicle vaccine in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Short-chain lipopolysaccharide mutants of serogroup B Neisseria meningitidis of potential value for production of outer membrane vesicle vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Meningitis bacterium is viable without endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Cross-reactive polyclonal antibodies to the inner core of lipopolysaccharide from Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Outer membrane composition of a lipopolysaccharide-deficient Neisseria meningitidis mutant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Shaping of adaptive immune responses to soluble proteins by TLR agonists: a role for IFN-alpha/beta

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Type I interferons produced by dendritic cells promote their phenotypic and functional activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

A vaccine carrier derived from Neisseria meningitidis with mitogenic activity for lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens. Carbohydrate sequence specificity of the mouse monoclonal antibodies that r

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Lipopolysaccharide endotoxins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Cutting edge: Immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Neisserial porin-induced dendritic cell activation is MyD88 and TLR2 dependent

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Interleukin-10 and the interleukin-10 receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Interleukin-6: from basic science to medicine--40 years in immunology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Immunology. Stimulating killer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Cross-presentation, dendritic cells, tolerance and immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Role of Toll-like receptors in costimulating cytotoxic T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Very small size proteoliposomes derived from Neisseria meningitidis: An effective adjuvant for generation of CTL responses to peptide and protein antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Biochemical and functional characterization of membrane blebs purified from Neisseria meningitidis serogroup B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Regulatory dendritic cells act as regulators of acute lethal systemic inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Molecular basis of bacterial outer membrane permeability

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Intranasal immunisation with inactivated RSV and bacterial adjuvants induces mucosal protection and abrogates eosinophilia upon challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Differential activation of human and mouse Toll-like receptor 4 by the adjuvant candidate LpxL1 of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

Antigen-specific T-cell responses in humans after intranasal immunization with a meningococcal serogroup B outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.109

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2009.01.109

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19368771

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19368771

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48004357&oldid=2181284270"